Arthur Costin
Family Medicine · Bellefontaine, OHNPI 1427071166
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 99.7% of the total across 200 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 25 manufacturers, the largest accounting for just 19.1% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2019 at $759 and has fallen 91.5% since, to $65 in 2023.
Across 200 payments — averaging $12.88 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Pfizer$493
- Novo Nordisk$298
- AstraZeneca$239
- Amarin Pharma, Inc.$186
- Merck$173
- AbbVie$113
- plus $1K from 19 others
What the payments were for
- Food & beverage$2,568100%
- Education$70%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Pfizer | 54 | $493 |
| Novo Nordisk | 27 | $298 |
| AstraZeneca | 16 | $239 |
| Amarin Pharma, Inc. | 13 | $186 |
| Merck | 11 | $173 |
| AbbVie(2 entities) | 8 | $113 |
| Abbott | 6 | $109 |
| Novartis | 8 | $107 |
| GSK | 8 | $104 |
| Sanofi-aventis U.S. LLC | 7 | $101 |
| Lilly USA, LLC | 7 | $95 |
| Amgen | 4 | $83 |
| Johnson & Johnson | 4 | $78 |
| Mylan Specialty L.p. | 4 | $59 |
| Currax Pharmaceuticals LLC | 4 | $56 |
| Biohaven Pharmaceuticals, Inc. | 4 | $52 |
| Bayer | 3 | $50 |
| Astellas Pharma US Inc | 3 | $49 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 2 | $26 |
| Avanir Pharmaceuticals, Inc. | 2 | $26 |
| Nestle Healthcare Nutrition Inc. | 1 | $18 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $17 |
| Boehringer Ingelheim | 1 | $17 |
| Kowa Pharmaceuticals America, Inc. | 1 | $14 |
| Alkermes, Inc. | 1 | $11 |
How this compares
$2,576 in reported general payments places this provider in the 75th percentile of 3,983 family medicine providers in Ohio.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Midodrine Hcl | 13 | $382 |
Paid to pharmacies, not to this prescriber.
Other family medicine in Bellefontaine
- Kwabena OtengSpringdale$2M
- Brian BeesleyColumbus$1.4M
- Darshana PatelBeachwood$648K
- Thomas GraceFindlay$503K
- Susan RatayAshtabula$379K
- Shannon TrotterSpringfield$348K
- Michael HeileCincinnati$272K
- Bradley EverlyMaumee$266K
- Tricia BedrickCuyahoga Falls$259K
- David NeidhardtLima$248K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.